Stocks-MRNA-Moderna Inc

MRNA Moderna Inc

0 0 (0%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Moderna Inc's revenues increased by 4.29% and amounted to 19.26B. Net income decreased by 31.47% to 8.36B. Net assets decreased by NaN to 19.12B and EPS decreased from 28.29 to 20.12.
MRNA's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
31.87%
Net Profit Margin
-209.17%
Operating Margin
-29.96%
Return On Investment
14.35%